Contributors

Aaron Lapat

Managing Partner
Bruce Rychlik

Managing Partner, Life Sciences
Erik Lundh

Managing Partner
Jesse Hershman

Partner
Jonathan Fortescue

Managing Partner
Park Square Executive Search
Stacey Lerner

Partner

Park Square Executive Search Archive

ALZHEIMER’S DRUG DEVELOPMENT COMPANY COGNITION THERAPEUTICS APPOINTS KENNETH I. MOCH PRESIDENT & CEO

Park Square Executive Search

10/28/2016 12:00:00 AM

https://www.passle.net/Content/Images/passle_logo-186px.png Passle https://passle.net

Park Square Executive Search

Cognition Therapeutics, Inc., a clinical stage neuroscience therapeutics company, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer of the company. Mr. Moch will also join the company’s Board of Directors.

http://cogrx.com/2016/10/28/alzheimers-drug-development-company-cognition-therapeutics-appoints-kenneth-i-moch-president-ceo/

unknownx500

More posts by Park Square Executive Search

Park Square has placed Seth Skousen as CISO/VP, Security & Compliance at re:Members

Park Square has placed Seth Skousen as CISO/VP, Security & Compliance at re:Members

Park Square Executive Search

Park Square has placed Eric Klostermann as Vice President, Cloud & AI Services at Promevo

Park Square has placed Eric Klostermann as Vice President, Cloud & AI Services at Promevo

Park Square Executive Search

Park Square Places Bryan Dsouza as Global Head of Marketing at Automata

Park Square Places Bryan Dsouza as Global Head of Marketing at Automata

Park Square Executive Search

Thong Q. Le and Paul Sekhri Join Board of Directors at Deep Genomics

Thong Q. Le and Paul Sekhri Join Board of Directors at Deep Genomics

Park Square Executive Search

Vaxess Announces Vice President of Manufacturing

Vaxess Announces Vice President of Manufacturing

Park Square Executive Search

Recent posts from Park Square Executive Search

Life Sciences Quarterly Newsletter from Park Square Executive Search

Life Sciences Quarterly Newsletter from Park Square Executive Search

Erik Lundh

Time to update the list...

Time to update the list...

Aaron Lapat

Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO

Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO

Erik Lundh

Dr. Laura Carter joins Character Biosciences as CSO

Dr. Laura Carter joins Character Biosciences as CSO

Erik Lundh

Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions

Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions

Erik Lundh

repost cancel

As a free user, you can like posts.

To repost this post to your own Passle blog, you will need to upgrade your account.

For plans and pricing, please contact our sales team at sales@passle.net

Sorry, you don't have permission to repost or create posts.

cancel